Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin may help treat various diseases and is influenced by magnetic fields, but more research is needed.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Activating Tgr5 may help treat hair loss and bone loss.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Alopecia areata causes hair loss and needs personalized care to manage its emotional and social effects.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Major depression disorder increases the risk of alopecia areata, and vice versa.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Vitamin A affects hair loss and immune response in alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.